The diffuse parenchymal lung diseases (DPLDs) are a heterogeneous group of conditions affecting the pulmonary parenchyma (interstitial) and/or alveolar lumen. IPF (Idiopathic Pulmonary Fibrosis) is a chronic interstitial pneumonia of unknown causes. It is commonest form of DPLD but its treatment response is very poor. On the other hand, NSIP (Non-Specific Interstitial Pneumonia) can still be a variant of DPLD with better treatment response and prognosis. Here we discussed a young female with NSIP with good response to steroid.
Mrs. Tahera 22 years old normotensive, non-diabetic housewife hailing from Ambikapur, Faridpur admitted to Diabetic Association Medical College Hospital on 16 th May 2017 with complaints of cough with exertional breathlessness for 3 months. Cough was dry and progressively increasing in intensity. Shortness of breath initially experienced only on strenuous exercise, but progressively increasing in intensity, now she feels shortness of breath on mild exertion. There was no history of diurnal or seasonal variation and not aggravated on dust or fumes. She mentioned about chest pain during coughing but no history of haemoptysis, joint pain, swelling or oral ulcer. She gave no history of loss of appetite or weight loss. Her bowel and bladder habits were normal. She had no history of contact with any tuberculosis patient.
On general examination, she was dyspnoeic, cyanosed, mildly anaemic, having clubbing. Her pulse was 68 b/min, BP-120/70mm Hg, and RR-25 breaths/min. On examination of respiratory system, her breath sound was vesicular, bilateral basal end inspiratory fine crepitation was present, which was not altered by coughing, and bilateral chest expansibility symmetrically reduced. Her investigation findings are shown in table I. Besides these we advised for lung biopsy, but patient party refused.
On the background of clinical findings and HRCT findings, we started prednisolone 0.5 mg/kg/day for one month, tapered every 2 weeks to 5mg/day and then was maintained in 5 mg/day and N-acetylcysteine related ILD are associated with a worse prognosis, with death occurring as a result of both respiratory failure and serious associated co-morbidities 6 .
The distinct term of NSIP was first used by pathologists (Katzenstein) and later separately by radiologists. NSIP patients are frequently women in younger ages. This condition can present with other underlying disorders such as collagen vascular diseases or due to medications and lead to pulmonary fibrosis and at the same time chronic HP. Many times the etiology is idiopathic. In HRCT compared to Usual Interstitial Pneumonia (UIP), there is often less peripheral distribution and ground glass opacities consistent with inflammation seen. Pathologically, there is the uniformity of the interstitium, increased cellularity or fibrosis, but less honey combing. Yet, often it is difficult to distinguish fibrosing NSIP form IPF/UIP [7] [8] [9] .
Recent studies have shown that NSIP, even when initially diagnosed as an idiopathic form of NSIP, might be associated with an autoimmune background that later reveals itself as an organ-specific or a systemic autoimmune disease 10 . In a Cohort study of 27 idiopathic NSIP patients, more than 50% of the cases developed an autoimmune disease after a mean followup of 22 months 11 . So my patient also needs long term follow up. On the other hand, the response to the question of whether NSIP in rheumatologic diseases is the same as idiopathic NSIP is very difficult, particularly since in pathologic samples the signs of bronchiectasis or granuloma may not be found 12 .
Overall, the ATS/ERS workshop committee has used the logical diagnosis of NSIP for middle-aged women and nonsmokers without clinical and serologic evidence for collagen vascular disease 12 . Even in some situations, NSIP has clinically been used in cases of undifferentiated connective tissue disorder 13 .
We believe that using the term NSIP and UIP provides the suggestion that in NSIP, steroids have absolute indication and the prognosis is better. On the other hand, UIP has poor prognosis and steroids are not useful. Yet, this is not the practical approach and the management of patients is individually based. It has previously been supported that NSIP is used for the cases discussed above. In the ATS/ERS 2002 categorization, grey area exists in this differentiation. The purpose of using distinct diagnostic entities due to variability in pathology, clinics and prognostics has been accepted. It can be concluded, that NSIP has been pathologically accepted as a distinct entity, but clinically it is used for middle aged women, nonsmokers with HRCT pattern consistent with NSIP 4 and response is good with steroid.
Conclusion:
NSIP is a rare variety of DPLD but it is potentially responsive to systemic steroid. We can diagnose it on HRCT finding of ground glass opacity with reticular shadow specially in middle aged female with the help of histopathological findings. NSIP patient may present simultaneously with connective tissue disease, may be diagnosed later on, or may never with connective tissue disease.
